Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies
Keri N. Althoff(Bloomberg (United States)), Stephen J. Gange(Johns Hopkins University), Robert Dubrow(Yale University), Joseph J. Eron(University of North Carolina at Chapel Hill), Amy C. Justice(Yale University), Marina B. Klein(Royal Victoria Regional Health Centre), Gregory M. Lucas(Johns Hopkins University), Kate Buchacz(Centers for Disease Control and Prevention), Michael J. Silverberg(Kaiser Permanente), Lisa P. Jacobson(Johns Hopkins University), Ángel M. Mayor(Central University of the Caribbean), Heidi M. Crane(University of Washington), Cynthia M. Boyd(Johns Hopkins University), Michael A. Horberg(Kaiser Permanente), Kelly A. Gebo(Atrium Health Wake Forest Baptist), M. John Gill(University of Calgary), Sonia Napravnik(University of North Carolina at Chapel Hill), James H. Willig(Northwestern University), Kathryn Anastos(Albert Einstein College of Medicine), William C. Mathews(Northwestern University), Gregory D. Kirk(Uganda Cancer Institute), Vincent Lo Re(University of Pennsylvania), Richard D. Moore(Johns Hopkins University), Fidel Desir(Johns Hopkins University), Timothy R. Sterling(Vanderbilt University Medical Center), Mari M. Kitahata(University of Washington), Frank J. Palella(Northwestern University), Daniel B. Klein(University of California, Berkeley), Chad J. Achenbach(Northwestern University), Cherise Wong(Pfizer (United States)), Anita Rachlis(University of Toronto), Kenneth Lichtenstein(National Jewish Health), Yuezhou Jing(Northwestern University), Charles S. Rabkin(National Cancer Institute), Jennifer E. Thorne(Johns Hopkins University), Pragna Patel(Northwestern University)
Cited by 140
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k